About
Nancy Isaac (J.D. , M.P.H.) is the Vice President of Clinical Affairs, Regulatory Affairs & Quality Neo Tract. Nancy joined NeoTract, Inc. in January 2011 as the Vice President of Clinical Affairs, Regulatory Affairs and Quality. Nancy has over 20 years of experience in the regulated industry including basic research, regulatory affairs, quality assurance, corporate compliance and clinical research. She has worked with devices, drugs, combination products, IVDs and biologics in various therapeutic areas. Prior to NeoTract, Nancy was Vice President of Regulatory Affairs and Quality for Neuraltus Pharmaceuticals. Before Neuraltus, Nancy was Senior Vice President of Clinical and Regulatory Affairs, and Quality Assurance for Broncus Technologies, Inc. Before joining Broncus in 2005, she was on the operating committee and served as the VP of Regulatory and Quality for Aerogen. When she left Becton Dickinson, she was the World Wide VP of Regulatory and Quality for BD Biosciences. She
Position in the VCSift Database
- • 1 investors hold the VP, Clinical Affairs, Regulatory Affairs & Quality role in VCSift. Nancy Isaac is one of them.
- • 7,285 investors are based in San Francisco, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- San Francisco, US
Contact Information
Find more investors like Nancy
Search Investors